-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
5-[(1E)-2-(4-Hydroxyphenyl)ethenyl]-1,2,3-benzenetriol, also known as the pharmaceutical intermediate, is an important compound widely used in the pharmaceutical and chemical industries.
The production process of this compound involves several steps, each of which must be carefully controlled to ensure the purity and quality of the final product.
Step 1: Synthesis of the Initial Raw Material
The synthesis of the initial raw material, 2-(4-hydroxyphenyl)ethyl acrylate, is the first step in the production process of 5-[(1E)-2-(4-Hydroxyphenyl)ethenyl]-1,2,3-benzenetriol.
This raw material is usually synthesized by a multi-step process that involves the reaction of phenol with acrylic acid in the presence of an acid catalyst.
The purified raw material is then used as the starting material for the next step.
Step 2: Esterification Reaction
The esterification reaction involves the reaction of 2-(4-hydroxyphenyl)ethyl acrylate with benzaldehyde in the presence of an acid catalyst.
This reaction is carried out at a controlled temperature and pressure to ensure maximum yield and purity.
The product of this reaction is a mixture of 5-(2-(4-hydroxyphenyl)ethenyl)-1,2,3-benzenetriol and 5-(2-(3-hydroxyphenyl)ethenyl)-1,2,3-benzenetriol.
Step 3: Deprotection Reaction
The deprotection reaction involves the removal of the acetyl group from the product of the esterification reaction.
This is achieved by treating the product with a strong acid, such as hydrochloric acid, in the presence of a solvent such as ether.
The resulting product is 5-[(1E)-2-(4-Hydroxyphenyl)ethenyl]-1,2,3-benzenetriol.
Step 4: Purification
The purification process involves the separation of the desired product from any impurities that may be present in the reaction mixture.
This is typically done using a combination of crystallization, recrystallization, and chromatography techniques.
The purified product is then dried and sieved to remove any remaining impurities.
Step 5: Formulation
The final step in the production process of 5-[(1E)-2-(4-Hydroxyphenyl)ethenyl]-1,2,3-benzenetriol is the formulation of the product into the desired dosage form.
This may involve the addition of excipients, such as fillers, binders, and lubricants, to the purified product to create a stable and effective tablet or capsule.
Quality Control
Quality control is critical in the production process of 5-[(1E)-2-(4-Hydroxyphenyl)ethenyl]-1,2,3-benzenetriol.
This involves testing the purity, potency, and stability of the final product at various stages of the manufacturing process.
This may include tests for physical and chemical properties, such as pH, density, and moisture content, as well as biological tests to ensure that the product is safe and effective for use in humans.
Conclusion
The production process of 5-[(1E)-2-(4-Hydroxyphenyl)ethenyl]-1,2,3-benzenetriol involves several steps, each of which must be carefully controlled to ensure the purity and quality of the final product.
Quality control is critical throughout the production process to ensure that the final product meets all necessary standards for safety and effectiveness.
With proper production and quality control processes in place, 5-[(1E)-2-(4-Hydroxyphenyl)ethenyl]-1,2,3-benzenetriol can be produced as a high-quality pharmaceutical intermediate for use in a variety of applications.